A Novel Seventeen-Gene Metabolic Signature for Predicting Prognosis in Colon Cancer

Figure 2

Kaplan–Meier estimates of colon cancer patients using the metabolic signature: (a) TCGA database; (b) incorporative GEO database; (c) stage I, II in TCGA database; (d) stage III, IV in TCGA database.

(a)

(b)

(c)

(d)